GSK Sells Haleon Shares Valued Around $1.24 Billion Through Discounted Placing
17 Janeiro 2024 - 4:44AM
Dow Jones News
By Michael Susin
GSK said it has sold a stake in Haleon valued around 978 million
pounds ($1.24 billion), reducing its stake in the
consumer-healthcare business to around 4.2%.
The British pharmaceutical giant said Wednesday that it has sold
300 million Haleon shares at an offer price of 326 pence a share.
This represents a discount of 2.3% from Tuesday's closing price of
333.6 pence prior to the announcement.
U.S. pharma giant Pfizer also holds a 32% stake in Haleon, which
was spun out of GSK and Pfizer's consumer-healthcare business.
Write to Michael Susin at michael.susin@wsj.com
(END) Dow Jones Newswires
January 17, 2024 02:29 ET (07:29 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
GSK (NYSE:GSK)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
GSK (NYSE:GSK)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024